dc.contributor.author
Casanovas Taltavull, Teresa
dc.contributor.author
Peña Cala, Maria Carmen
dc.date.issued
2018-09-12T12:28:05Z
dc.date.issued
2018-09-12T12:28:05Z
dc.date.issued
2017-02-01
dc.date.issued
2018-07-24T12:11:16Z
dc.identifier
https://hdl.handle.net/2445/124486
dc.description.abstract
Key Clinical Message: Our case report discusses the usefulness of administering romiplostim as a second-line treatment before splenectomy in a cirrhotic patient with immune thrombocytopenia who developed corticosteroid-induced Cushing's syndrome. Corticosteroids were tapered and consequently withdrawn. The patient made a full recovery postsplenectomy.
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: https://doi.org/10.1002/ccr3.667
dc.relation
Clinical Case Reports, 2017, vol. 5, num. 2, p. 159-163
dc.relation
https://doi.org/10.1002/ccr3.667
dc.rights
cc by (c) Casanovas Taltavull, Teresa; Peña Cala, Maria Carmen, 2017
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject
Síndrome de Cushing
dc.subject
Administració de medicaments
dc.subject
Cushing's syndrome
dc.subject
Administration of drugs
dc.title
Romiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
